Target intelligence / Profile preview

Mitogen-activated protein kinase kinase kinase 9 mRNA 3′ untranslated region (MAP3K9 mRNA 3′UTR)

Target
MAP3K9 mRNA 3′UTR
Molecular classification
mRNA regulatory region, 3′ untranslated region
01

Overview

The MAP3K9 mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the messenger RNA encoding Mitogen-activated protein kinase kinase kinase 9 (MAP3K9), also known as Mixed Lineage Kinase 1 (MLK1). This region contains multiple binding sites for microRNAs (miRNAs), such as miR-7, miR-148a, miR-34a, and miR-125b, which post-transcriptionally regulate MAP3K9 expression by inducing mRNA degradation or inhibiting translation (nih.gov, researchgate.net). MAP3K9 is a serine/threonine kinase that activates the JNK and p38 MAPK pathways, playing a pivotal role in cell proliferation, apoptosis, and stress responses (nih.gov). Dysregulation of the MAP3K9 mRNA 3′UTR, often through the downregulation of its targeting miRNAs or mutations in binding sites, leads to MAP3K9 overexpression, which is associated with the progression of various cancers, including lung, pancreatic, and gastric carcinomas, as well as inflammatory diseases like osteoarthritis (nih.gov, aging-us.com). Consequently, the MAP3K9 mRNA 3′UTR is considered a potential therapeutic target for RNA-based interventions, such as miRNA mimics or antisense oligonucleotides, aimed at restoring normal MAP3K9 levels to inhibit tumor growth and metastasis (europeanreview.org, nih.gov).

Other names
MLK1 mRNA 3′UTRMixed lineage kinase 1 mRNA 3′UTRMAP3K9 3′ untranslated regionMAP3K9 3′UTR
02

Mechanism of action

miRNA-mediated translational repression and mRNA degradation

03

Biological functions

Regulation of gene expressionmRNA stabilityTranslation inhibitionSignal transductionCell proliferationApoptosis
04

Disease associations

CancerInflammationOsteoarthritisNeurodegenerative disease
05

Safety considerations

Off-target effects of RNA-based therapiesSystemic toxicityPotential for compensatory signaling pathway activationImmunogenicity of synthetic oligonucleotides
06

Interacting drugs

miR-7 mimic

7 more in the full profile.

07

Biomarkers

MAP3K9 mRNA expressionMAP3K9 protein expressionmiR-148a-3p levelsmiR-7 levelsmiR-34a levels

Beyond the preview

Go deeper on Mitogen-activated protein kinase kinase kinase 9 mRNA 3′ untranslated region (MAP3K9 mRNA 3′UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 9 mRNA 3′ untranslated region (MAP3K9 mRNA 3′UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call